It has recently been shown that it is possible to prevent Rhnegative individuals from being immunized by Rh-positive blood. This was first established under experimental conditions in which Rh-negative male volunteers were injected with 5 ml. of Rh-positive blood and then given 50 ml. of plasma containing incomplete anti-D (Finn et al., 1961 ; Clarke et al., 1963) . This method was then applied in a clinical trial in which the subjects were Rh-negative primiparae just delivered of an ABO compatible Rh-positive child and had 0.25 ml. or more of circulating foetal blood after delivery (Woodrow et al., 1965; B.M.7., 1966) . In the trial 5 ml. of gammaglobulin containing approximately 1,000 jug. of anti-D was injected intramuscularly within 36 hours of delivery. The results convincingly demonstrated that anti-D formation by the mothers was prevented, and it appears likely that this treatment will prove to be a practical method of preventing Rh-haemolytic disease of the newborn.
It remains to be determined what constitutes an appropriate dose of gammaglobulin and whether this needs to be varied in different cases. It has been shown that there is a direct relation between the number of Rh-positive foetal cells in the maternal circulation after delivery and the risk of subsequent immunization (Woodrow et al., 1965) , but this may only hold up to a certain volume of Rh-positive blood (see below). In most cases the volumes of foetal blood involved are quite small. Thus an analysis of foetal cell counts carried out in Liverpool on 701 primiparae just after the delivery of ABO compatible babies showed that no foetal blood was found in 333 cases, up to 1 ml. was found in 330, 1-5 ml. in 32, 5-20 ml. in four, and more than 20 ml. in two. Further work since the first clinical trial makes it seem likely that in the great majority of Rh-negative women the prevention of immunization as a result of pregnancy can be effected by the injection of 1 ml. of gammaglobulin, representing about 200 ttg. of anti-D (Clarke et al., 1966; Clarke, 1967 (Kleihauer and Betke, 1960 Mollison, 1967) found Rh antibody in only 30 out of 60 Rh-negative subjects who had received a " single transfusion " of Rh-positive blood. Freda et al. (1964) found that 10 ml. of Rh-positive blood induced the formation of anti-D in 6 out of 13 male volunteers. In a survey being carried out in Liverpool 10 Rh-negative primiparae were observed who had at least 3 ml. of circulating Rh-positive foetal blood after delivery (the mean volume being 5 ml.), and of these, four developed anti-D during the ensuing six months. It may be that though a fairly close relation exists between the volume of Rh-positive blood and the risk of immunization over the lower range of volume, the risk may not appreciably increase much above 50% as the volume rises over the 5-10 ml. range. (Jandl et al., 1957 ; Mollison, 1967) . The relation of haemoglobinuria to the renal damage which may occur with incompatible transfusions remains uncertain. Mollison (1967) points out that such an eventuality is much more likely to occur where destruction of red cells is intravascular, and suggests that some other factor, possibly resulting in impaired renal blood flow, must be present in these cases.
Instances have been described of haemolytic transfusion reactions, associated with haemoglobinuria and oliguria and attributed to Rh antibodies, but as a rule a detailed knowledge of the serological status of the patients is lacking. Vogel et al. (1943) gave accounts of two such patients in whom Rh agglutinins were found.
There remains some uncertainty about the degree of risk of renal damage that is involved when a large amount of Rhpositive blood is destroyed by incomplete anti-D gammaglobulin. A cautious approach seems advisable at present, but it is likely that further experience in treating women with large transplacental haemorrhages will provide useful information. were seen in the two patients receiving approximately 1,000 /ug. of anti-D in the form of gammaglobulin intramuscularly.
The evidence suggests that Rh immunization by quite large transplacental haemorrhage can be safely prevented by giving anti-D gammaglobulin. A cautious approach to the use of this method in dealing with Rh-incompatible transfusions in women before or during the child-bearing period seems justified. Passively administered anti-Rh has been extraordinarily successful in suppressing primary immunization which would otherwise occur in certain Rh-negative women after pregnancy. However, the amount of foetal red cells found in a mother's circulation after delivery is less than 1.5 ml. in 98% of cases (Clarke et al., 1966) , and so far there is little experience of trying to suppress primary immunization when much larger amounts are involved, either as a result of transplacental haemorrhage or of inadvertent transfusion of Rh-positive blood.
We here report two cases in which Rh-negative patients received relatively large amounts of Rh-positive red cells-in one case by transplacental haemorrhage and in the other by blood transfusion-and in which relatively small amounts of passively administered anti-Rh failed to prevent primary immunization.
Case 1
The patient, aged 26, gave birth to her first infant on 17 May 1967; she had not been pregnant before nor had she received a blood transfusion. The infant was very pale and appeared moribund; six hours after birth it was found to have a haemoglobin concentration of 6.3 g./100 ml. The mother was group B Rhnegative and the infant group B Rh-positive; the mother's serum did not contain anti-Rh and the infant's direct antiglobulin test was negative. A transplacental haemorrhage was suspected, and examination of the mother's blood by the acid-elution method showed numerous foetal red cells; from counts made in this laboratory it was estimated that approximately 1 in 36 of the red cells stained darkly. If it is assumed that the mother's red cell volume was 1,500 ml. and that the acid-elution method detects about 70% of the true number of foetal red cells present (unpublished observations) the volume of foetal red cells in the mother's circulation was approximately 60 ml.
The infant was given a blood transfusion and made a satisfactory recovery.
At about 60 hours after birth the mother was given an intramuscular injection of ganmuaglobulin (batch " A ") estimated to contain a total of 500 ,ug. of IgG anti-D; the preparation contained no detectable agglutinating (IgM) anti-D. Estimates of the proportion of foetal cells present in the mother's blood were made at 2, 3, 6, and 13 days after the injection of anti-D; the results are shown in Fig. 1 . Half the cells disappeared in four to five days and all had gone by 13 days. Anti-D could be detected in the patient's plasma (indirect antiglobulin test) 48 hours after the injection, and it was still just detectable 20 days after the injection. A sample of serum taken from the mother seven weeks after the birth of the infant showed that anti-Rh was present to a titre of 2; five weeks later the titre was 16, and five weeks after this (four months after the birth of the infant) it was 32. Case 2
The patient, aged 21, had an abortion on 30 June 1967. She was admitted to hospital next day because of considerable bleeding, and was transfused with two units of group 0 Rh-positive blood (containing a total of approximately 400 ml. of red cells) between the evening of 1 July and the morning of 2 July. It was then discovered that the patient was group 0 Rh-negative, and she was referred to us for treatment. On the evening of 3 July, 48 hours after the beginning of the blood transfusion, gammaglobulin (batch " B ") containing 1,000 pg. of IgG anti-D was given intramuscularly; the preparation contained no agglutinating anti-D. 
